The NPRM cites 42 U.S.C. 289 as its statutory authority, but it does not seem to care much about following the language of the statute.
Showing posts with label clinical. Show all posts
Showing posts with label clinical. Show all posts
Friday, September 18, 2015
NPRM. Statute? What Statute?
Posted by
Zachary M. Schrag
at
10:30 AM
Labels:
clinical,
definitions,
Federal Register,
law,
NPRM,
regulations
0
comments
Sunday, March 17, 2013
On Signing the Markingson Petition
By April 1942, the Pentagon was 40 percent over budget, partly because it had been enlarged since first approved, but mostly because the original estimate of $35 million had never been realistic. Lieutenant General Brehon Somervell delayed telling Congress, but in June he finally sent Colonel Leslie Groves to appear before a House Apppropriations subcommittee.
Posted by
Zachary M. Schrag
at
12:36 PM
Labels:
biomedical,
clinical,
compliance,
Dreger,
drugs,
elliott,
markingson,
minnesota,
misconduct,
OHRP,
psychiatry,
transparency,
vulnerable
0
comments
Saturday, September 29, 2012
SACHRP Still Lacks Social Scientists
OHRP has announced new members of the Secretary's Advisory Committee on Human Research Protections (SACHRP):
Eissenberg's PhD is in Experimental Psychology, and his "primary area of research is the behavioral pharmacology of drugs of abuse, focusing primarily on nicotine/tobacco." Ossorio's PhD is in Microbiology and Immunology. So that's four new members with background in biomedical research of one kind or another, none whose primary interests are in non-medical research.
- Chair Designate: Jeffrey R. Botkin, M.D., M.P.H., Professor of Pediatrics and Medical Ethics, Associate Vice President for Research, University of Utah. Term: October 15, 2012 - October 15, 2016
- Thomas Eissenberg, Ph.D., Professor, Department of Psychology and Institute for Drug and Alcohol Studies; Director, Clinical Behavioral Pharmacology Laboratory, Virginia Commonwealth University. Term: October 9, 2012 - October 9, 2016
- Owen Garrick, M.D., M.B.A., President and CEO, Bridge Clinical Research, Inc. Term: October 15, 2012 - October 15, 2016
- Pilar Ossorio, J.D., Ph.D., Associate Professor of Law and Bioethics, University of Wisconsin-Madison. Term: October 15, 2012 - October 15, 2016
Eissenberg's PhD is in Experimental Psychology, and his "primary area of research is the behavioral pharmacology of drugs of abuse, focusing primarily on nicotine/tobacco." Ossorio's PhD is in Microbiology and Immunology. So that's four new members with background in biomedical research of one kind or another, none whose primary interests are in non-medical research.
Thursday, August 16, 2012
IRBs Impeded Harvard Dissertation on Addiction and Incarceration
Kimberly Sue, a medical anthropologist in Harvard's MD/PhD program, reports that IRB review can seem "a hassle, a nuisance or a stumbling block, as we seek to enact a more relevant and engaged era of anthropology."
[Kimberly Sue "Are IRBs a Stumbling Block for an Engaged Anthropology?" Somatosphere, 9 August 2012, http://somatosphere.net/2012/08/are-irbs-a-stumbling-block-for-an-engaged-anthropology.html . h/t Michelle Meyer]
[Kimberly Sue "Are IRBs a Stumbling Block for an Engaged Anthropology?" Somatosphere, 9 August 2012, http://somatosphere.net/2012/08/are-irbs-a-stumbling-block-for-an-engaged-anthropology.html . h/t Michelle Meyer]
Posted by
Zachary M. Schrag
at
2:18 PM
Labels:
anthropology,
biomedical,
clinical,
crime,
drugs,
ethnography,
Harvard,
horror stories,
prisoners,
vulnerable
5
comments
Friday, July 29, 2011
Elliott Wants to Scrap IRBs
Carl Elliott, author of White Coat, Black Hat: Adventures on the Dark Side of Medicine, calls IRBs "incapable" and wants them replaced.
[Carl Elliott, Useless Pharmaceutical Studies, Real Harm, New York Times, 29 July 2011.]
[Carl Elliott, Useless Pharmaceutical Studies, Real Harm, New York Times, 29 July 2011.]
Posted by
Zachary M. Schrag
at
10:17 AM
Labels:
ANPRM,
biomedical,
clinical,
Dreger,
elliott,
expertise,
press,
Stark
1 comments
Subscribe to:
Posts (Atom)
